| |
|
|
|
|
|
|
|||
|
Blood, 1 July 2008, Vol. 112, No. 1, pp. 56-63. Prepublished online as a Blood First Edition Paper on April 16, 2008; DOI 10.1182/blood-2007-07-099309.
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Guanine exchange factor RalGDS mediates exocytosis of Weibel-Palade bodies from endothelial cells1 Department of Plasma Proteins, Sanquin Research and Landsteiner Laboratory Academic Medical Centre (AMC), University of Amsterdam, Amsterdam, The Netherlands; 2 Division of Molecular Neuroendocrinology, Medical Research Council (MRC) National Institute for Medical Research, London, United Kingdom; 3 Cell Biology Research Group, Robarts Research Institute, Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON; 4 Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; 5 Department of Vascular Medicine AMC, University of Amsterdam, Amsterdam, The Netherlands; and 6 Department of Molecular Cell Biology, Sanquin Research and Landsteiner Laboratory AMC, University of Amsterdam, Amsterdam, The Netherlands
The small GTP-binding protein Ral has been implicated in regulated exocytosis via its interaction with the mammalian exocyst complex. We have previously demonstrated that Ral is involved in exocytosis of Weibel-Palade bodies (WPBs). Little is known about intracellular signaling pathways that promote activation of Ral in response to ligand binding of G protein–coupled receptors. Here we show that RNAi-mediated knockdown of RalGDS, an exchange factor for Ral, results in inhibition of thrombin- and epinephrine-induced exocytosis of WPBs, while overexpression of RalGDS promotes exocytosis of WPBs. A RalGDS variant lacking its exchange domain behaves in a dominant negative manner by blocking release of WPBs. We also provide evidence that RalGDS binds calmodulin (CaM) via an amino-terminal CaM-binding domain. RalGDS association to CaM is required for Ral activation because a cell-permeable peptide comprising this RalGDS CaM-binding domain inhibits Ral activation and WPB exocytosis. Together our findings suggest that RalGDS plays a vital role in the regulation of Ral-dependent WPB exocytosis after stimulation with Ca2+- or cAMP-raising agonists.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||